Weihong Jiang

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Single-cell profiling identifies mechanisms of inflammatory heterogeneity in chronic rhinosinusitis

Weiqing Wang, Yi Xu, Lun Wang et al. · Nature Immunology · 2022 · 170 citations

Life Sciences, Cell Biology, Immunology +16

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Gregory G. Schwartz, Vera A. Bittner, Patricio López‐Jaramillo et al. · Journal of the American College of Cardiology · 2021 · 141 citations · Full text

Medicine, Cardiology, Pharmacology +17

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 122 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE

Jeffrey I. Weitz, Sylvia Haas, Walter Ageno et al. · Journal of Thrombosis and Thrombolysis · 2020 · 115 citations · Full text

Medicine, Oncology, Cancer Epidemiology +11